mHealth Intervention in Increasing HPV Vaccinations in College Students

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

101 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-10-18

Study Completion Date

2017-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This randomized pilot trial studies how well a mobile health (mHealth) intervention works in increasing human papillomavirus (HPV) vaccination among college students at the Ohio State University. mHealth educational intervention may communicate information about HPV vaccination and increase HPV vaccine uptake in college students.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Self-Collected Swabs for Primary Human Papilloma Virus (HPV) Screening

NCT05989464

HPV

UNKNOWN

Normalizing HPV Vaccination in Preteens With a Serious Video Game

NCT04627298

Human Papillomavirus

COMPLETED NA

Prospective Evaluation of Self-Testing to Increase Screening

NCT03898167

Cervical Cancer Human Papillomavirus Infection

COMPLETED NA

Strengthening Physician Communication About HPV Vaccines

NCT02456077

HPV Immunization Status

COMPLETED NA

Communication Strategy to PROMOTE HPV Vaccination in Pharmacies: PROMOTE Study

NCT04660331

Human Papillomavirus Infection

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

PRIMARY OBJECTIVES:

I. Pilot test an mHealth HPV vaccine intervention for college students to establish feasibility and acceptability.

II. Obtain preliminary efficacy data on whether the mHealth HPV vaccine intervention increases HPV vaccine initiation compared to the control group.

SECONDARY OBJECTIVES:

I. Examine whether the mHealth HPV vaccine intervention affects secondary outcomes compared to the control group.

OUTLINE: Participants are randomized to 1 of 2 arms.

ARM I: Participants receive targeted HPV vaccine narrative-style video via the mobile-friendly website. Participants also receive monthly HPV vaccination reminders via email or by text message.

ARM II: Participants receive standard information about HPV and then HPV vaccine information statement (VIS) via the mobile-friendly website.

After completion of study, participants are followed up at 3 and 7 months.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy Subject

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Arm I (mHealth HPV vaccine intervention)

Participants receive targeted HPV vaccine narrative-style video via the mobile-friendly website. Participants also receive monthly HPV vaccination reminders via email or by text message.

Group Type EXPERIMENTAL

Media Intervention

Intervention Type OTHER

Receive targeted HPV vaccine narrative-style video

Survey Administration

Intervention Type OTHER

Ancillary studies

Arm II (standard HPV information and HPV VIS)

Participants receive standard information with the HPV Vaccine Information Statement via the mobile-friendly website.

Group Type ACTIVE_COMPARATOR

Informational Intervention

Intervention Type OTHER

Receive standard HPV vaccine information (HPV VIS)

Survey Administration

Intervention Type OTHER

Ancillary studies

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Informational Intervention

Receive standard HPV vaccine information (HPV VIS)

Intervention Type OTHER

Media Intervention

Receive targeted HPV vaccine narrative-style video

Intervention Type OTHER

Survey Administration

Ancillary studies

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Currently enrolled as a first year Ohio State University (OSU) student on the Columbus campus
* Being able to read English
* Not having received any doses of the HPV vaccine

Minimum Eligible Age

18 Years

Maximum Eligible Age

25 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes